Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s interface revision has been updated from v3.5.2 to v3.5.3, reflecting a change to the system/version display rather than any study record content.
    Difference
    0.1%
    Check dated 2026-04-23T21:53:00.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The record history shows the addition of revision v3.5.2 and the deletion of revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:25:05.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:39:19.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    New revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T19:58:34.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The history now includes a new Revision: v3.4.2 entry, and the prior government funding notice and Revision: v3.4.1 entry were removed. These changes relate to page versioning and site notices rather than the trial data or study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T04:55:16.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and the page revision tag v3.4.1, replacing v3.4.0; no study data, eligibility, or results were affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T05:34:08.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.